Healthpeak Properties, Inc. PEAK
17.10 0.00 (+0.00%)
At closeMar 1, 2024, 4:00 PM EST
16.51 Day range 17.14
15.24 52-week range 22.38
Analyst view
Consensus: buy
Buy
Price target (mean) 21.82 +27.6% upside
Now 17.10
- Target (low)
- 18.00
- Target (mean)
- 21.82
- Target (high)
- 26.00
Ratings (-1m) 15 9 buy · 4 hold · 2 sell
- Strong buy5
- Buy4
- Hold4
- Sell2
- Strong sell0
Recommendation trend
- 1 month ago 15
- 2 months ago 15
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.07 | 0.02 – 0.10 | 0.22 | -68.2% | 565.71M | +7.6% | 4 |
| Next quarter | 0.09 | 0.03 – 0.13 | 0.09 | 0.0% | 645.20M | +20.4% | 4 |
| Current year | 0.38 | 0.18 – 0.47 | 0.56 | -32.1% | 2.50B | +14.6% | 6 |
| Next year | 0.55 | 0.24 – 0.79 | 0.38 | +44.7% | 2.66B | +6.2% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 10, 2023 | Exane BNP Paribas | Initiated | — | Underperform |
| Oct 4, 2023 | Scotiabank | Maintained | Sector Perform | Sector Perform |
| Oct 2, 2023 | Wedbush | Initiated | — | Neutral |
| Sep 6, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 24, 2023 | Barclays | Maintained | Overweight | Overweight |
| Jun 14, 2023 | Mizuho | Reiterated | Buy | Buy |
| Jun 14, 2023 | Citigroup | Reiterated | Neutral | Neutral |
| Jun 11, 2023 | Mizuho | Reiterated | Buy | Buy |
| May 3, 2023 | RBC Capital | Maintained | — | Sector Perform |
| Apr 23, 2023 | Mizuho | Upgrade | Neutral | Buy |
| Apr 19, 2023 | Wells Fargo | Initiated | — | Equal-Weight |
| Apr 18, 2023 | Wells Fargo | Initiated | — | Equal-Weight |
| Apr 5, 2023 | Citigroup | Downgrade | Buy | Neutral |
| Mar 30, 2023 | Scotiabank | Downgrade | Sector Outperform | Sector Perform |
| Mar 9, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Feb 27, 2023 | Citigroup | Maintained | — | Buy |
| Feb 9, 2023 | Barclays | Maintained | — | Overweight |
| Jan 2, 2023 | Jefferies | Upgrade | Hold | Buy |
| Dec 13, 2022 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Nov 20, 2022 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Oct 31, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Sep 27, 2022 | Wolfe Research | Upgrade | Peer Perform | Outperform |
| Sep 8, 2022 | Barclays | Maintained | — | Overweight |
| Aug 30, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jul 28, 2022 | Mizuho | Maintained | — | Neutral |
| Jul 14, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Jul 7, 2022 | Citigroup | Upgrade | Neutral | Buy |
| Jun 29, 2022 | Jefferies | Maintained | — | Hold |
| May 31, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| May 19, 2022 | RBC Capital | Maintained | — | Outperform |
